Observational study of elinzanetant for menopause symptoms
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tracks how women use elinzanetant for menopause symptoms and how well it works for them. It does not test a new drug; it simply observes women who are already taking it, which helps gather real-world information about its effectiveness and side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who has just started taking elinzanetant for menopause symptoms like hot flashes.
- You agree to answer questionnaires on a device with internet access.
- You are not taking part in any other research study with treatments outside your usual care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body handles two different forms of a drug called elinzanetant in healthy women. It helps doctors understand the drug's effects and may guide future treatment options.
This study follows women in Canada who are starting fezolinetant, a new medication for hot flashes during menopause. Researchers will track how well it works and how you feel while using it in your regular doctor's care.
This study tests a medication called fezolinetant to see if it helps with hot flashes and also looks at its effects on blood vessels and the brain. It is for women who are going through menopause and having frequent moderate to severe hot flashes.
This study tests an investigational drug called asimadoline to see if it can reduce hot flashes and night sweats in women going through menopause. It may help women who have frequent, bothersome symptoms and are not currently using other treatments for them.
This study looks at how hot flashes in midlife women might be connected to heart disease risk. Researchers want to see if managing hot flashes can improve heart health.
This study tests an experimental vaginal cream (AZU-101) for postmenopausal women who have vaginal dryness and pain during sex. The goal is to see if it can improve these symptoms without the risks of hormone treatments.
Hear when a new Vasomotor Symptoms (VMS) Associated With Menopause trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.